Vor bio reports third quarter 2023 financial results and provides company update

Cambridge, mass., nov. 07, 2023 (globe newswire) -- vor bio (nasdaq: vor), a clinical-stage cell and genome engineering company, today reported financial results for the three-month period ended september 30, 2023, and provided a business update.
VOR Ratings Summary
VOR Quant Ranking